Quarterly report pursuant to Section 13 or 15(d)

Business Combination (Tables)

v3.5.0.2
Business Combination (Tables)
6 Months Ended
Jun. 30, 2016
Business Combinations [Abstract]  
Schedule of Business Acquisitions by Acquisition, Consideration Transferred
The aggregate acquisition consideration was $173.4 million, consisting of (in thousands):

Cash consideration
$
96,006

Total share consideration:
 
     Actual number of shares issued
790

     Multiplied by: Ligand closing share price on January 8, 2016
$
97.92

Total share consideration
77,373

Total consideration
$
173,379

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
he acquisition consideration was preliminarily allocated to the acquisition date fair values of acquired assets and assumed liabilities as follows (in thousands):

     Cash and cash equivalents
$
3,504

     Accounts receivable
5

     Income tax receivable
140

     Prepaid expenses and other current assets
2

     Deferred tax liabilities, net
(56,114
)
     Intangible asset with finite life - core technology
167,000

     Liabilities assumed
(1,279
)
     Goodwill
60,121

Total consideration
$
173,379


Schedule of Pro Forma Information
The following table presents supplemental pro forma information for the three and six months ended June 30, 2016 and June 30, 2015, as if the acquisition of OMT had occurred on January 1, 2015 (in thousands except for EPS):

 
Three months ended
Six months ended
 
June 30,
June 30,
 
2016
 
2015
2016
 
2015
Revenue
$
19,521

 
$
19,818

$
51,645

 
$
36,971

Net (loss) income
$
(6,170
)
 
$
19,483

$
2,758

 
$
18,166

 
 
 
 
 
 
 
Basic (loss) income per share:
$
(0.30
)
 
$
0.99

$
0.13

 
$
0.92

Diluted (loss) income per share:
$
(0.30
)
 
$
0.92

$
0.13

 
$
0.87